StreetAccount Summary - Trading higher/lower: Asia mid-morning
StreetAccount Summary - Trading higher/lower: Japan mid-day
Fund in early-stage talks to buy Otsuka Holdings's stake in MicroPort Scientific - Bloomberg (15:43 HKT/16:43 JT) (HK$7.04, 0.00)
Otsuka Holdings reports Q1 net income attributable ¥85.00B vs FactSet ¥67.69B [6 est, ¥57.20-80.66B] (¥6792.0000, +9)
Otsuka Holdings completes up-to-¥70.00B buyback (¥6772.0000, 0)
Follow-up: US President Donald Trump says the US will unveil "major" tariff on imports of pharmaceutical goods - NBC News
StreetAccount Sector Summary - Healthcare Post-Market
StreetAccount Sector Summary - Healthcare Pre-Market
Otsuka Holdings initiated market perform at Bernstein (¥7290.0000, 0)
Otsuka submits biologics license application for Sibeprenlimab to FDA in treatment of Immunoglobulin A Nephropathy (¥8074.0000, 0)
Powered by FactSet Research Systems Inc.